What to watch with CYP2D6 and Allergie?

CYP2D6 is a key enzyme for metabolizing many drugs, including some antihistamines (e.g., diphenhydramine, hydroxyzine) and other allergy medications. Individuals with a slow CYP2D6 variant (poor metabolizers) may process these drugs more slowly, leading to increased side effects (drowsiness, dizziness) or reduced efficacy. However, CYP2D6 does not predict allergy risk itself – that is more influenced by genes like HLA, IL-4, or FCER1A. A DNA test for CYP2D6 can help guide dosing of allergy medications but should not replace medical advice. Evidence for drug metabolism impact is human-moderate; for allergy causation it is weak. Caveat: not all allergy drugs rely on CYP2D6 (e.g., cetirizine, loratadine use other pathways).